Business briefs: J&J, Manhattan Research, plus July job cuts

Share this article:

Johnson & Johnson said it will sell off its feminine-hygiene unit today to Energizer Holdings, Inc. The brands included in the buyout are Stayfree, Carefree and o.b. Collective price tag: $185 million. Energizer already owns the Playtex product line and plans to combine the new brands into that business to expand its presence in the category. The deal is estimated to close in the fourth quarter.

Manhattan Research unveiled a study today, surveying 1,831 physicians online on how sales reps can better utilize the iPad for e-detailing. Findings show tablet presentations are failing docs due to unimpressive content, and that the "sales dance is frequently clumsy." Content must be “crisp, with intuitive navigation, responsive design, and attention to basics,” like fonts and distance from eye to screen. Among other insights, physicians said they don't use pharma resources (branded product websites) because of concerns about bias and because they aren't sure they'll find the information they need.” MDs are looking for assistance in navigating macro trends like ACOs, and the shift from fee-for-service reimbursement toward qualitative incentives. Life science companies "must be aware of how these trends are impacting their customers and how they can help healthcare professionals adapt to this fast-changing world.”

Challenger Grey & Christmas' July job-cut report shows workforce reductions were led by the healthcare sector, which planned to shed 6,843 jobs last month. This represents the “highest number of cuts for this sector since 9,558 healthcare job cuts were recorded in November 2009,” the advisory firm noted in a press release. The consultancy stated that healthcare organizations have now cut 29,794 jobs this year—which is 59% more than the 18,770 planned job cuts announced by this time last time year. Challenger says a number of factors hurt hospitals' bottom line: cuts in Medicare reimbursements due to sequestration and reform; state cuts in Medicaid funding; and fewer patients as high-deductible insurance policies discourage them from seeking health services.

Molecular diagnostics company Cepheid rolled out its “Ride Against TB” campaign in tandem with the American Lung Association (ALA) at the American Association for Clinical Chemistry and American Society for Clinical Laboratory Science annual meeting in Houston. The campaign aims to raise awareness on the “need for improved diagnostic solutions for the rapid detection of tuberculosis,” and to raise funds to benefit the ALA. The campaign features Paul Teutul Jr. of Paul Jr. Designs, who recently starred in the TV show American Chopper. The campaign also features a contest to win a new custom bike. Contestants will also have an opportunity to donate directly to the ALA.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.